2023 Form 5500 filing — Cyclerion Therapeutics, Inc. 401(K) Savings Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240912135544NAL0008622033001) for Cyclerion Therapeutics, Inc. 401(K) Savings Plan, reported by Cyclerion Therapeutics, Inc. under EIN 83-1895370 and plan number 001. It reports 94 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$20.7MReported net assets$20,687,215
Participants94
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20240912135544NAL0008622033001
Plan sponsor
Cyclerion Therapeutics, Inc.
EIN
83-1895370
Plan number
001
Location
Cambridge, MA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$20.7M total assets
Net assets$20.7MLiabilities$0
Money in vs. money out
Total income / additions$4.4M
Total expenses$6.7M
Benefits paid / distributions$6.7M
Contributions
Employer$83K
Participant$229.6K
Full reported line items
Total assets (EOY)
$20,687,215
Total liabilities (EOY)
$0
Net assets (EOY)
$20,687,215
Employer contributions
$83,022
Participant contributions
$229,581
Total income / additions
$4,434,657
Benefits paid
$6,722,066
Administrative expenses
-$4,449
Total expenses
$6,717,617
Net increase / (decrease)
-$2,282,960

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20240912135544NAL0008622033001 cover?
It is the 2023 Form 5500 filing for Cyclerion Therapeutics, Inc. 401(K) Savings Plan, reported by Cyclerion Therapeutics, Inc. (EIN 83-1895370).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages